Affitope-AD03

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAffitope-AD03
Drug Alias NameAlzheimer AD-03MimoVaxAffitope-AD03AD-03
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunostimulantsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAffiris Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffiris Ag
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A